Open Access
| Issue |
BIO Web Conf.
Volume 198, 2025
5th ASEAN Microbial Biotechnology Conference (AMBC 2025)
|
|
|---|---|---|
| Article Number | 04004 | |
| Number of page(s) | 15 | |
| Section | Biotechnology | |
| DOI | https://doi.org/10.1051/bioconf/202519804004 | |
| Published online | 03 December 2025 | |
- WHO, WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020, available at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020 (2020) [Google Scholar]
- J. Sun, W.-T. He, L. Wang, A. Lai, X. Ji, X. Zhai, G. Li, M.A. Suchard, J. Tian, J. Zhou, M. Veit, S. Su, COVID-19: Epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol. Med. 26, 483 (2020). https://doi.org/10.1016/j.molmed.2020.02.008 [CrossRef] [Google Scholar]
- WHO, COVID-19 cases, world, available at: https://data.who.int/dashboards/covid19/cases (2025) [Google Scholar]
- M. Ogawa, Y. Shirasago, I. Tanida, S. Kakuta, Y. Uchiyama, M. Shimojima, K. Hanada, M. Saijo, M. Fukasawa, Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus. J. Infect. Chemother. 27, 397 (2021). https://doi.org/10.1016/j.jiac.2020.10.015 [Google Scholar]
- J. Langland, B. Jacobs, C.E. Wagner, G. Ruiz, T.M. Cahill, Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses. Antiviral Res. 160, 143 (2018). https://doi.org/10.1016/j.antiviral.2018.10.021 [Google Scholar]
- H. Ohashi, K. Watashi, W. Saso, K. Shionoya, S. Iwanami, T. Hirokawa, T. Shirai, S. Kanaya, Y. Ito, K.S. Kim, T. Nomura, T. Suzuki, K. Nishioka, S. Ando, K. Ejima, Y. Koizumi, T. Tanaka, S. Aoki, K. Kuramochi, T. Suzuki, T. Hashiguchi, K. Maenaka, T. Matano, M. Muramatsu, M. Saijo, K. Aihara, S. Iwami, M. Takeda, J.A. McKeating, T. Wakita, Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. 24, 102367 (2021). https://doi.org/10.1016/j.isci.2021.102367 [Google Scholar]
- F. Simko, T. Baka, Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: Potential allies in the COVID-19 pandemic instead of a threat? Clin. Sci. 135, 1009 (2021). https://doi.org/10.1042/CS20210182 [Google Scholar]
- K. Liu, B. Hong, S.-T. He, S. Du, J. Ke, L. Tian, T. Tao, Y. Zhang, K. Li, H. Chang, M. Li, X. An, L. Song, Z. Zhang, L. Liu, H. Pan, H. Fan, Y. Tong, The potential mechanisms and material basis of Fuzheng Jiedu decoction broad-spectrum inhibiting coronaviruses. Virologica Sinica. 40, 125 (2025). https://doi.org/10.1016/j.virs.2024.12.007 [Google Scholar]
- S. Mantovani, B. Oliviero, S. Varchetta, A. Renieri, M.U. Mondelli, TLRs: Innate immune sentries against SARS-CoV-2 infection. Int. J. Mol. Sci. 24, 8065 (2023). https://doi.org/10.3390/ijms24098065 [Google Scholar]
- B. Mdkhana, N.S. Sharif-Askari, R.K. Ramakrishnan, S. Goel, Q. Hamid, R. Halwani, Nucleic acid-sensing pathways during SARS-CoV-2 infection: Expectations versus reality. J. Inflamm. Res. 14, 199 (2021). https://doi.org/10.2147/JIR.S277716 [Google Scholar]
- A. Roos, A.J. Nauta, D. Broers, M.C. Faber-Krol, L.A. Trouw, J.W. Drijfhout, M.R. Daha, Specific inhibition of the classical complement pathway by C1q-binding peptides. J. Immunol. 167, 7052 (2001). https://doi.org/10.4049/jimmunol.167.12.7052 [Google Scholar]
- B.M. Flude, G. Nannetti, P. Mitchell, N. Compton, C. Richards, M. Heurich, A. Brancale, S. Ferla, M. Bassetto, Targeting the complement serine protease MASP-2 as a therapeutic strategy for Coronavirus infections. Viruses. 13, 312 (2021). https://doi.org/10.3390/v13020312 [Google Scholar]
- P. Gonzâlez-Maldonado, N. Alvarenga, A. Burgos-Edwards, M.E. Flores-Giubi, J.E. Barua, M.C. Romero-Rodriguez, R. Soto-Rifo, F. Valiente-Echeverria, P. Langjahr, G. Cantero-Gonzâlez, P.H. Sotelo, Screening of natural products inhibitors of SARS-CoV-2 entry. Molecules. 27, 1743 (2022). https://doi.org/10.3390/molecules27051743 [Google Scholar]
- Y.S. Wijayasinghe, P. Bhansali, R.E. Viola, M.A. Kamal, N.K. Poddar, Natural products: A rich source of antiviral drug lead candidates for the management of COVID-19. Curr. Pharm. Des. 27, 3526 (2021). https://doi.org/10.2174/1381612826666201118111151 [Google Scholar]
- M.A. Shah, A. Rasul, R. Yousaf, M. Haris, H.I. Faheem, A. Hamid, H. Khan, A.H. Khan, M. Aschner, G.E.S. Batiha, Combination of natural antivirals and potent immune invigorators: A natural remedy to combat COVID-19. Phytother. Res. 35, 6530 (2021). https://doi.org/10.1002/ptr.7228 [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.